Austin Health

Title
ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions.
Publication Date
2022-06
Author(s)
Zuberi, Sameer M
Wirrell, Elaine
Yozawitz, Elissa
Wilmshurst, Jo M
Specchio, Nicola
Riney, Kate
Pressler, Ronit
Auvin, Stephane
Samia, Pauline
Hirsch, Edouard
Galicchio, Santiago
Triki, Chahnez
Snead, O Carter
Wiebe, Samuel
Cross, J Helen
Tinuper, Paolo
Scheffer, Ingrid E
Perucca, Emilio
Moshé, Solomon L
Nabbout, Rima
Subject
Dravet syndrome
developmental and epileptic encephalopathy
epilepsy of infancy with migrating focal seizures
infantile spasms
self-limited epilepsies
Type of document
Journal Article
OrcId
https://orcid.org/0000-0003-3015-8282
https://orcid.org/0000-0001-8230-8364
https://orcid.org/0000-0001-7328-1796
https://orcid.org/0000-0002-8120-0287
https://orcid.org/0000-0002-1122-3555
https://orcid.org/0000-0002-2905-6839
https://orcid.org/0000-0003-3874-9749
https://orcid.org/0000-0002-7427-0439
https://orcid.org/0000-0003-0833-8850
https://orcid.org/0000-0002-1061-9099
https://orcid.org/0000-0001-7345-4829
https://orcid.org/0000-0002-2311-2174
https://orcid.org/0000-0001-8703-223X
https://orcid.org/0000-0001-9427-9476
https://orcid.org/0000-0001-5877-4074
DOI
10.1111/epi.17239
Abstract
The International League Against Epilepsy (ILAE) Task Force on Nosology and Definitions proposes a classification and definition of epilepsy syndromes in the neonate and infant with seizure onset up to 2 years of age. The incidence of epilepsy is high in this age group and epilepsy is frequently associated with significant comorbidities and mortality. The licensing of syndrome specific antiseizure medications following randomized controlled trials and the development of precision, gene-related therapies are two of the drivers defining the electroclinical phenotypes of syndromes with onset in infancy. The principal aim of this proposal, consistent with the 2017 ILAE Classification of the Epilepsies, is to support epilepsy diagnosis and emphasize the importance of classifying epilepsy in an individual both by syndrome and etiology. For each syndrome, we report epidemiology, clinical course, seizure types, electroencephalography (EEG), neuroimaging, genetics, and differential diagnosis. Syndromes are separated into self-limited syndromes, where there is likely to be spontaneous remission and developmental and epileptic encephalopathies, diseases where there is developmental impairment related to both the underlying etiology independent of epileptiform activity and the epileptic encephalopathy. The emerging class of etiology-specific epilepsy syndromes, where there is a specific etiology for the epilepsy that is associated with a clearly defined, relatively uniform, and distinct clinical phenotype in most affected individuals as well as consistent EEG, neuroimaging, and/or genetic correlates, is presented. The number of etiology-defined syndromes will continue to increase, and these newly described syndromes will in time be incorporated into this classification. The tables summarize mandatory features, cautionary alerts, and exclusionary features for the common syndromes. Guidance is given on the criteria for syndrome diagnosis in resource-limited regions where laboratory confirmation, including EEG, MRI, and genetic testing, might not be available.
Link
Citation
Epilepsia 2022; 63(6): 1349-1397
Jornal Title
Epilepsia

Files:

NameSizeformatDescriptionLink